Evidence based personalized fluid decisions
More than 80% of hospitalized patients receive IV fluids.1 However, 1 in 5 patients may suffer complications or morbidity due to inappropriate administration of IV fluids.2
Until IV fluid therapy is correctly managed, optimal outcomes may not be achieved. The amount and type of IV fluid must be considered before administration.2,3 Clinicians need real-time, precise physiologic data to make well-informed choices about whether fluid is the right intervention and, if so, what type and how much is appropriate to support the patient's pathway to recovery.
Baxter offers a range of fluid management products designed to help clinicians improve outcomes by making evidence-based, personalized fluid decisions. To find out more visit our new website: https://emeamedicationdelivery.baxter.com/contact
References:
1.Yucha CB, Hastings-Tolsma M, Szevereny NM. Differences among intravenous extravasations using four common solutions. J Intraven Nurs. 1993;16(5):277-281.
2. National Institute for Health and Care Excellence. Intravenous fluid therapy in adults in hospital. NICE Clinical guideline 174, 2013.
3. Nursing Times. NICE guidance on giving intravenous fluids. January 2014.
EMA-MD6-230024 v1.0 11/2023